| 1 |
34170488 | Human cell-based anti-inflammatory effects of rosiglitazone. | 2022 Jan |
2 |
| 2 |
30488141 | Peroxisome Proliferator-Activated Receptor γ Agonist Rosiglitazone Protects Blood-Brain Barrier Integrity Following Diffuse Axonal Injury by Decreasing the Levels of Inflammatory Mediators Through a Caveolin-1-Dependent Pathway. | 2019 Jun |
1 |
| 3 |
21031343 | Effects of rosiglitazone/metformin fixed-dose combination therapy and metformin monotherapy on serum vaspin, adiponectin and IL-6 levels in drug-naïve patients with type 2 diabetes. | 2011 Feb |
3 |
| 4 |
21424914 | The effects of rosiglitazone and metformin on inflammation and endothelial dysfunction in patients with type 2 diabetes mellitus. | 2011 Dec |
1 |
| 5 |
19923143 | Bradykinin and high glucose promote renal tubular inflammation. | 2010 Mar |
1 |
| 6 |
20921996 | Rosiglitazone regulates IL-6-stimulated lipolysis in porcine adipocytes. | 2010 Oct |
7 |
| 7 |
19155534 | Protective effect of peroxisome proliferator-activated receptor-gamma agonists on activated renal proximal tubular epithelial cells in IgA nephropathy. | 2009 Jul |
1 |
| 8 |
19443277 | Crosstalk between peroxisome proliferator-activated receptor-gamma and angiotensin II in renal tubular epithelial cells in IgA nephropathy. | 2009 Aug |
1 |
| 9 |
19673614 | Use of peroxisome proliferator-activated receptor gamma agonists as adjunctive treatment for Plasmodium falciparum malaria: a randomized, double-blind, placebo-controlled trial. | 2009 Sep 15 |
1 |
| 10 |
19782427 | Molecular mechanisms underlying the pro-inflammatory synergistic effect of tumor necrosis factor alpha and interferon gamma in human microvascular endothelium. | 2009 Dec |
1 |
| 11 |
20003221 | Direct rosiglitazone action on steroidogenesis and proinflammatory factor production in human granulosa-lutein cells. | 2009 Dec 9 |
1 |
| 12 |
17922475 | Rosiglitazone increases matrix production and quenches inflammation: studies in human cells. | 2008 Mar-Apr |
1 |
| 13 |
18541328 | The effect of rosiglitazone on oxidative stress and insulin resistance in overweight individuals. | 2008 Aug |
1 |
| 14 |
18583261 | [Effects of rosiglitazone on inflammatory reaction and insulin resistance in obese patients with newly diagnosed type 2 diabetes]. | 2008 Jun |
1 |
| 15 |
17141246 | Stimulation of the peroxisome proliferator-activated receptor gamma (PPAR gamma) and the expression of selected blood monocyte cytokine genes in diabetic macroangiopathy. | 2007 Oct |
1 |
| 16 |
17224000 | Effects of rosiglitazone and metformin on inflammatory markers and adipokines: decrease in interleukin-18 is an independent factor for the improvement of homeostasis model assessment-beta in type 2 diabetes mellitus. | 2007 Feb |
1 |
| 17 |
16137694 | Effects of rosiglitazone on postprandial leukocytes and cytokines in type 2 diabetes. | 2006 May |
3 |
| 18 |
16223437 | Inhibitory effect of PPAR-gamma activator on IL-6 and mPGES protein expression in PBMC induced by homocysteine. | 2005 Oct |
1 |
| 19 |
14749206 | Effects of rosiglitazone on gene expression in subcutaneous adipose tissue in highly active antiretroviral therapy-associated lipodystrophy. | 2004 Jun |
1 |
| 20 |
15526907 | Anti-inflammatory effect of PPARgamma in cultured human mesangial cells. | 2004 Sep |
1 |
| 21 |
12163427 | Effect of rosiglitazone treatment on nontraditional markers of cardiovascular disease in patients with type 2 diabetes mellitus. | 2002 Aug 6 |
2 |
| 22 |
12509942 | [Anti-inflammatory effect of peroxisome proliferator-activated receptor-gamma incultured human mesangial cells]. | 2002 Oct 10 |
1 |